TRIAX Trademark

Trademark Overview

On Thursday, July 16, 2020, a trademark application was filed for TRIAX with the United States Patent and Trademark Office. The USPTO has given the TRIAX trademark a serial number of 90056913. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, October 13, 2021. This trademark is owned by Arbele Corp.. The TRIAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields
triax

General Information

Serial Number90056913
Word MarkTRIAX
Filing DateThursday, July 16, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, October 13, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 1, 2020

Trademark Statements

Goods and ServicesPharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 14, 2020
Primary Code042
First Use Anywhere DateWednesday, June 10, 2020
First Use In Commerce DateThursday, October 1, 2020

Trademark Owner History

Party NameArbele Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedmond, WA 98052
Party NameArbele Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBellevue, WA 98006

Trademark Events

Event DateEvent Description
Tuesday, February 28, 2023AMENDMENT CORRESPONDENCE ENTERED
Wednesday, October 13, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, October 13, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, March 31, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 31, 2021NON-FINAL ACTION E-MAILED
Wednesday, March 31, 2021SU - NON-FINAL ACTION - WRITTEN
Sunday, March 7, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 10, 2021USE AMENDMENT FILED
Monday, March 1, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 10, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, January 26, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 1, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 1, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 28, 2020ASSIGNED TO EXAMINER
Friday, August 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 22, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 22, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 22, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 20, 2020NEW APPLICATION ENTERED

Related Keywords

triax pharmaceutical development research fields biotechnology